We have read and written many articles and blogs regarding this topic but it continues to fascinate everyone including researchers. The frequency and variety of persistent symptoms after COVID-19 are definitely stumping the medical community! In a study published in JAMA Open, a systematic review of 45 studies including 9,751 participants with COVID-19, the median proportion of individuals who experienced …
The following was published by the CDC Morbidity and Mortality Weekly Report (MMWR) from June 4, 2021: End-stage renal disease (ESRD) is a condition in which kidney function has permanently declined such that renal replacement therapy is required to sustain life. The mortality rate for patients with ESRD in the United States has been declining since 2001, however, during the …
In a study published in JAMA Otolaryngology-Head and Neck Surgery, 89% of the SARS-CoV-2-positive, mildly symptomatic patients who had a sudden onset of altered sense of smell or taste, experienced a complete resolution or improvement of these symptoms. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection. At 4 weeks from the initial survey of mildly …
A recent JAMA article discusses how delirium emerged as a well-recognized complication of COVID-19, with particular importance due to its high prevalence and mortality. Unfortunately, early signs of delirium (also referred to as acute brain failure) are often “missed”. During the COVID-19 pandemic, reversible contributors to delirium must be addressed and approaches for delirium prevention and management can be built …
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease swept the globe, anecdotal reports of a potential exacerbating effect of non-steroidal, anti-inflammatory drugs (NSAIDs), including ibuprofen and aspirin, on COVID-19 emerged, leading to some warnings against the use of NSAIDs. In a study conducted in the United States, United Kingdom, and Sweden using the COVID Symptom Study app about …
The effectiveness of coronavirus testing depends not only on the number of tests performed but also on who is getting tested. Testing may be administered for a variety of reasons: to diagnose COVID-19 in symptomatic patients, to detect asymptomatic infection in persons exposed to infection or at high risk of transmitting infection to others (i.e., essential workers), to detect outbreaks …
In a recent article published in MedPage Today, medical experts at the American Academy of Neurology (AAN) annual meeting discussed COVID-19 vaccines and “long hauler” symptoms. “The question of vaccines and different neurological conditions has been studied over the years” said Walter Koroshetz, MD, director o the National institute of Neurological Disorders and Stroke (NINDS). “We don’t have any real …
In a news release from EurekaAlert, researchers at Columbia University say that they found no signs of virus inside the patients’ brain cells but saw many brain abnormalities that could explain the confusion and delirium seen in some patients with severe coronavirus and the lingering “brain fog” in those with mild disease. The study, which the authors called the largest …
A study of about 200 COVID-19 patients last year found that nearly half reported a loss of taste or smell. While most of them regained their senses within four weeks, roughly 10% reported their condition had been unchanged or worse. Doctors are still learning about this COVID-19 related symptom and what possible treatments could be helpful. Some physicians have begun …
